Sulfonamide-dihydrofolate reductase inhibitor combination

This page covers all Sulfonamide-dihydrofolate reductase inhibitor combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Dihydropteroate synthase; Dihydrofolate reductase.

Targets

Dihydropteroate synthase; Dihydrofolate reductase

Marketed (2)

• Sulfamethoxazole Trimethoprim Combination · Baylor Research Institute · Infectious Disease
  Sulfamethoxazole-trimethoprim is a fixed-dose combination antibiotic that inhibits bacterial folate synthesis by blocking dihydropteroate synthase and dihydrofolate reductase, respectively.
• Sulfamethoxazole-Trimethoprim · National Institute of Allergy and Infectious Diseases (NIAID) · Infectious Disease
  Sulfamethoxazole-trimethoprim is a fixed-dose combination antibiotic that inhibits bacterial folate synthesis by blocking dihydrofolate reductase and dihydropteroate synthase.